CareAcross provides personalised support services for patients with cancer. Their focus is on sharing research findings and guidelines, and offer evidence-based approaches to improve quality of life for those living with cancer, whilst strengthening the relationship between the patient and their medical team.
CareAcross engages with thousands of patients diagnosed with many different cancers, providing services around patient engagement, real world evidence, clinical trial recruitment, and patient-reported outcomes.
The relationship between a patient and their doctor is unique, especially when it is about cancer. CareAcross set out to identify the needs and priorities of patients regarding this critical aspect of their experience with cancer.
M3 regularly partners with CareAcross by giving their members the opportunity to take part in our research studies and share their opinion on existing, and future, oncological therapies.
We partnered with CareAcross on this survey which aims to understand the needs of patients affected by different types of cancer.

mRNA vaccine immunity redefined as liver targeting and non-immune cells drive responses, challenging classic vaccine design

New ADHD model reframes it as a disorder of energy regulation, introducing Energy Deficit Hyperactivity Disorder and fresh neuroscience insights

Study shows bipolar II disorder linked to higher risk of early death, based on JAMA Network Opens population data and long-term analysis